Detalhe da pesquisa
1.
Hereditary cancer testing in a diverse sample across three breast imaging centers.
Breast Cancer Res Treat
; 203(2): 365-372, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861889
2.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076566
3.
Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicity.
Genet Med
; 24(3): 673-680, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906512
4.
Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.
J Genet Couns
; 31(5): 1164-1172, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617031
5.
Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer.
Salud Publica Mex
; 64(1): 41-48, 2022 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438911
6.
Germline mutations and age at onset of lung adenocarcinoma.
Cancer
; 127(15): 2801-2806, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858029
7.
Multigene assessment of genetic risk for women for two or more breast cancers.
Breast Cancer Res Treat
; 188(3): 759-768, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826040
8.
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(1): 77-102, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406487
9.
Rlip depletion prevents spontaneous neoplasia in TP53 null mice.
Proc Natl Acad Sci U S A
; 115(15): 3918-3923, 2018 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572430
10.
Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines.
Hum Mutat
; 41(9): 1555-1562, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485079
11.
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
BMC Cancer
; 20(1): 1053, 2020 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33138793
12.
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 159(3): 820-826, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010967
13.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
J Natl Compr Canc Netw
; 18(4): 380-391, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259785
14.
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
Hum Mutat
; 40(10): 1781-1796, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112363
15.
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Breast Cancer Res
; 21(1): 107, 2019 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533767
16.
Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2517-2521, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31445185
17.
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer
; 125(16): 2829-2836, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206626
18.
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
Br J Cancer
; 121(1): 15-21, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971774
19.
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Am J Hum Genet
; 98(5): 801-817, 2016 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153395
20.
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 175(2): 443-449, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756284